DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prohance (Gadoteridol) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (27)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prohance (Gadoteridol) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Prohance side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: 84 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Anaphylactic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2012-02-23
    End date: 2012-02-23

Prohance
    Indication: Lung Neoplasm Malignant
    Start date: 2012-02-23
    End date: 2012-02-23



Possible Prohance side effects in male

Reported by a physician from Germany on 2012-07-05

Patient: male

Reactions: Contusion, Circulatory Collapse, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 62 year old female

Reported by a physician from Germany on 2012-05-08

Patient: 62 year old female

Reactions: Dyspnoea, Circulatory Collapse

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 72 year old male

Reported by a physician from Japan on 2012-04-18

Patient: 72 year old male

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-04-09
    End date: 2012-04-09

Prohance
    Indication: Metastases To Central Nervous System
    Start date: 2012-04-09
    End date: 2012-04-09

Other drugs received by patient: Chemotherapeutics



Possible Prohance side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06

Patient: 84 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Nausea, Dizziness, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-02-14
    End date: 2012-02-14

Prohance
    Indication: Ovarian Neoplasm
    Start date: 2012-02-14
    End date: 2012-02-14



Possible Prohance side effects in male

Reported by a physician from Germany on 2012-03-09

Patient: male

Reactions: Contusion, Circulatory Collapse, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-09

Patient: female

Reactions: Back Pain, Lacrimation Increased, Erythema, Eye Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-02

Patient: 84 year old female

Reactions: Blood Pressure Decreased, Oxygen Saturation Decreased, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 63 year old male

Reported by a physician from Japan on 2012-03-01

Patient: 63 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Brain Cancer Metastatic
    Start date: 2012-02-07
    End date: 2012-02-07

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-02-07
    End date: 2012-02-07

Other drugs received by patient: Norvasc; Halcion; Losartan Potassium and Hydrochlorothiazide



Possible Prohance side effects in female

Reported by a physician from United States on 2012-02-27

Patient: female, weighing 82.4 kg (181.3 pounds)

Reactions: Electrocardiogram ST Segment Depression, Periorbital Cellulitis, Hypertensive Emergency, Electrocardiogram QT Shortened, Angina Unstable, Vascular Graft Thrombosis, Haematemesis, Off Label Use, Ileus, Electrocardiogram T Wave Abnormal, Arteriovenous Fistula Site Complication, Dysphagia, Nausea, Nephrogenic Systemic Fibrosis, Hyperlipidaemia, Renal Failure, Diarrhoea, QRS Axis Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Optimark
    Dosage: 20 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-03-24
    End date: 2005-03-24

Prohance
    Dosage: 17 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-04-27
    End date: 2004-04-27

Other drugs received by patient: Norvasc; Synthroid; Zemplar; Atacand; Nephrocaps; Epogen; Renagel; Ferrlecit / 00345601 /; Insulin; Catapres / 00171101 /



Possible Prohance side effects in 84 year old female

Reported by a physician from Japan on 2012-02-23

Patient: 84 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Nausea, Dizziness, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 63 year old male

Reported by a physician from Japan on 2012-02-14

Patient: 63 year old male, weighing 76.0 kg (167.2 pounds)

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Brain Cancer Metastatic
    Start date: 2012-02-07
    End date: 2012-02-07

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-02-07
    End date: 2012-02-07

Other drugs received by patient: Losartan Potassium and Hydrochlorothiazide; Halcion; Norvasc



Possible Prohance side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Vision Blurred, Diastolic Dysfunction, Anaphylactic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Osteomyelitis
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Infection
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-12-19
    End date: 2011-12-19

Other drugs received by patient: Levothyroxine Sodium; Savella; Fluoxetine; Calcium; Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Spironolactone; Vitamin D; Advair Diskus 100 / 50; Bumex



Possible Prohance side effects in 60 year old female

Reported by a physician from Japan on 2012-02-02

Patient: 60 year old female, weighing 69.0 kg (151.8 pounds)

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-01-11
    End date: 2012-01-11

Prohance
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-01-11



Possible Prohance side effects in 36 year old female

Reported by a physician from Japan on 2012-01-30

Patient: 36 year old female

Reactions: Anaphylactic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Breast Cancer
    Start date: 2012-01-13
    End date: 2012-01-13

Prohance
    Indication: Diagnostic Procedure
    Start date: 2012-01-13
    End date: 2012-01-13



Possible Prohance side effects in 67 year old female

Reported by a physician from Japan on 2012-01-24

Patient: 67 year old female

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Neoplasm Malignant
    Start date: 2011-12-26
    End date: 2011-12-26

Prohance
    Indication: Diagnostic Procedure
    Start date: 2011-12-26
    End date: 2011-12-26



Possible Prohance side effects in 36 year old female

Reported by a physician from Japan on 2012-01-19

Patient: 36 year old female

Reactions: Abdominal Pain, Generalised Oedema, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-13

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Anaphylactic Shock, Diastolic Dysfunction, Vision Blurred

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Osteomyelitis
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Infection
    Start date: 2011-12-19
    End date: 2011-12-19

Other drugs received by patient: Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Calcium; Fluoxetine; Savella; Bumex; Advair Diskus 100 / 50; Vitamin D; Spironolactone; Levothyroxine Sodium



Possible Prohance side effects in 74 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: 74 year old female, weighing 73.0 kg (160.6 pounds)

Reactions: Syncope, Unresponsive To Stimuli, Feeling Hot

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Asthenia
    Start date: 2011-08-29
    End date: 2011-08-29

Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Multiple Sclerosis
    Start date: 2011-08-29
    End date: 2011-08-29

Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-08-29
    End date: 2011-08-29

Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Gait Disturbance
    Start date: 2011-08-29
    End date: 2011-08-29



Possible Prohance side effects in 62 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: 62 year old female

Reactions: Anaphylactic Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Mass
    Start date: 2011-05-03
    End date: 2011-05-03

Prohance
    Dosage: 15ml once intravenous (not otherwise specified)
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-05-03
    End date: 2011-05-03

Other drugs received by patient: Norvasc; Vasotec



Possible Prohance side effects in 53 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-05

Patient: 53 year old female

Reactions: Flushing, Pharyngeal Oedema, Chest Discomfort, Dyspnoea, Throat Irritation, Sneezing, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance

Other drugs received by patient: Levoxyl; Naprosyn



Possible Prohance side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-28

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Anaphylactic Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Infection
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Osteomyelitis
    Start date: 2011-12-19
    End date: 2011-12-19

Other drugs received by patient: Spironolactone; Acetaminop. W / Butalbital / Caff. / Codeine Phosp.; Savella; Fluoxetine; Vitamin D; Levothyroxine Sodium; Bumex; Advair Diskus 100 / 50; Calcium Acetate



Possible Prohance side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-21

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Respiratory Arrest, Sneezing

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Infection
    Start date: 2011-12-19
    End date: 2011-12-19

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-12-19
    End date: 2011-12-19



Possible Prohance side effects in 72 year old male

Reported by a consumer/non-health professional from United States on 2011-11-21

Patient: 72 year old male, weighing 97.5 kg (214.5 pounds)

Reactions: Restlessness, Urinary Incontinence, Dyskinesia, Toxicity To Various Agents, Tremor, NO Therapeutic Response, DRY Throat, Contrast Media Allergy, Hallucination, Asthenia, Nervousness, Muscle Spasms

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Prohance



Possible Prohance side effects in 82 year old male

Reported by a physician from Japan on 2011-11-15

Patient: 82 year old male

Reactions: Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2011-10-19
    End date: 2011-10-19

Prohance
    Indication: Metastases To Bone
    Start date: 2011-10-19
    End date: 2011-10-19



Possible Prohance side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-08

Patient: 57 year old male

Reactions: Renal Transplant, Nephrogenic Systemic Fibrosis, Immobile

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Prohance
    Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
    Start date: 2006-07-18
    End date: 2006-08-17

Prohance
    Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
    Start date: 2006-09-20
    End date: 2006-09-20

Prohance
    Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
    Start date: 2007-01-10
    End date: 2007-01-10

Prohance
    Dosage: 15 ml, single dose, 15 ml, single, 15 ml, single dose, 15 ml, single dose,
    Start date: 2007-05-01
    End date: 2007-05-01

Omniscan
    Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
    Indication: Central Nervous System Abscess
    Start date: 2006-05-13
    End date: 2006-05-13

Omniscan
    Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
    Indication: Central Nervous System Abscess
    Start date: 2006-08-23
    End date: 2006-08-23

Omniscan
    Dosage: 15 ml, single dose, intravenous;15 ml, single dose, intravenous; 15 ml, single dose, intravenous
    Indication: Central Nervous System Abscess
    Start date: 2006-08-31
    End date: 2006-08-31



Possible Prohance side effects in 38 year old female

Reported by a physician from Japan on 2011-11-03

Patient: 38 year old female

Reactions: Tetany

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prohance

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014